Cyberounds Logo
September 29, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
CME credit is no longer available for this conference.
Nicholas A. Tritos, M.D., D.Sc.

Nicholas A. Tritos, M.D., D.Sc, is Assistant Professor of Medicine, Harvard Medical School, and a member of the Neuroendocrine Unit/Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital, Boston, Massachusetts.

Within the past 12 months, Dr. Tritos has received grant support from Ipsen and Pfizer.

Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.

Release Date: 01/13/2015
Termination Date: 01/13/2018

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the role of pituitary surgery in patients with acromegaly
  • Describe the role of current and novel medical therapies in acromegaly
  • Review the role of pituitary radiation therapy in patients with acromegaly.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity